Development of a target identification approach using native mass spectrometry
Abstract A key step in the development of new pharmaceutical drugs is the identification of the molecular target and distinguishing this from all other gene products that respond indirectly to the drug. Target identification remains a crucial process and a current bottleneck for advancing hits throu...
Guardado en:
Autores principales: | Miaomiao Liu, Wesley C. Van Voorhis, Ronald J. Quinn |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/79735f1a181546f9a030b3da081e8bf6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
por: Michal Bassani-Sternberg, et al.
Publicado: (2016) -
Stochastic palmitoylation of accessible cysteines in membrane proteins revealed by native mass spectrometry
por: Remco N. P. Rodenburg, et al.
Publicado: (2017) -
Native mass spectrometry combined with enzymatic dissection unravels glycoform heterogeneity of biopharmaceuticals
por: Therese Wohlschlager, et al.
Publicado: (2018) -
DATABASE OF LEPTOSPIRA PROTEIN SPECTRA FOR MASS-SPECTROMETRY IDENTIFICATION
por: N. V. Breneva, et al.
Publicado: (2018) -
Reliable identification of protein-protein interactions by crosslinking mass spectrometry
por: Swantje Lenz, et al.
Publicado: (2021)